
    
      This is a multi-center, randomized, double blind, placebo controlled, parallel group, dose
      ranging study investigating the efficacy, safety, and pharmacokinetic profile of ANB020
      administered to adult subjects with moderate-to-severe atopic dermatitis.
    
  